HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Selma Ugurel Selected Research
Selma Ugurel Research Topics
Disease
95
Melanoma (Melanoma, Malignant)
04/2022 - 08/2002
56
Neoplasms (Cancer)
04/2022 - 01/2003
17
Merkel Cell Carcinoma
03/2022 - 05/2006
15
Neoplasm Metastasis (Metastasis)
03/2022 - 01/2003
15
Skin Neoplasms (Skin Cancer)
01/2022 - 03/2007
8
Disease Progression
05/2021 - 08/2002
4
Brain Neoplasms (Brain Tumor)
01/2022 - 09/2008
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 03/2007
3
Uveal melanoma
01/2022 - 06/2003
3
Dermatofibrosarcoma
01/2017 - 03/2007
2
Myasthenia Gravis
03/2021 - 01/2019
2
Fibrosis (Cirrhosis)
01/2021 - 01/2014
2
Inflammation (Inflammations)
01/2021 - 01/2021
2
Autoimmune Diseases (Autoimmune Disease)
01/2017 - 07/2006
2
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2014 - 07/2010
1
Cardiotoxicity
01/2022
1
Necrosis
01/2022
1
Cytokine Release Syndrome
10/2021
1
Testicular Neoplasms (Testicular Cancer)
06/2021
1
Transverse Myelitis (Necrotizing Myelitis)
03/2021
1
Brachial Plexus Neuritis (Parsonage Turner Syndrome)
03/2021
1
Headache (Headaches)
03/2021
1
Hypophysitis
03/2021
1
Neck Pain (Cervicalgia)
03/2021
1
Guillain-Barre Syndrome
03/2021
1
Diabetes Mellitus
01/2021
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021
1
Exanthema (Rash)
01/2021
1
Gastritis
01/2021
1
Infections
01/2021
1
Ketosis
01/2021
1
Neutropenia
01/2021
1
Pancreatitis
01/2021
Drug/Important Bio-Agent (IBA)
35
Immune Checkpoint Inhibitors
IBA
03/2022 - 01/2016
19
Biomarkers (Surrogate Marker)
IBA
04/2022 - 08/2002
15
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022 - 02/2007
14
Nivolumab
IBA
03/2022 - 01/2016
14
Ipilimumab
IBA
03/2022 - 11/2016
12
pembrolizumab
IBA
04/2022 - 01/2016
9
Antibodies
IBA
01/2022 - 05/2008
9
Phosphotransferases (Kinase)
IBA
05/2020 - 08/2004
7
DNA (Deoxyribonucleic Acid)
IBA
07/2017 - 07/2005
6
Pharmaceutical Preparations
IBA
01/2021 - 01/2003
6
Imatinib Mesylate (Gleevec)
FDA Link
01/2017 - 03/2007
5
Adenosine Triphosphate (ATP)
IBA
09/2017 - 01/2003
4
Vemurafenib
IBA
01/2021 - 01/2014
4
Programmed Cell Death 1 Receptor
IBA
01/2020 - 01/2017
4
Proteins (Proteins, Gene)
FDA Link
01/2020 - 08/2005
4
Paraffin
IBA
07/2017 - 04/2007
3
Antigens
IBA
06/2021 - 06/2004
3
Interferons
IBA
01/2020 - 09/2008
3
Monoclonal Antibodies
IBA
01/2020 - 07/2016
3
Dacarbazine (DIC)
FDA Link
Generic
09/2017 - 09/2008
3
Formaldehyde (Formol)
FDA Link
07/2017 - 01/2014
3
Histocompatibility Antigens Class I
IBA
01/2017 - 06/2004
3
Indicators and Reagents (Reagents)
IBA
08/2009 - 08/2002
2
avelumab
IBA
03/2022 - 07/2021
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2022 - 01/2021
2
trametinib
IBA
01/2022 - 01/2018
2
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
10/2021 - 01/2017
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
11/2020 - 01/2020
2
Messenger RNA (mRNA)
IBA
01/2020 - 01/2014
2
Histone Deacetylases (Histone Deacetylase)
IBA
06/2019 - 02/2006
2
Biological Products
IBA
01/2019 - 01/2018
2
dabrafenib
IBA
01/2018 - 01/2014
2
denileukin diftitox (Ontak)
FDA Link
01/2014 - 07/2010
2
Paclitaxel (Taxol)
FDA Link
Generic
03/2013 - 03/2012
2
Ligands
IBA
02/2013 - 08/2009
2
Peptides (Polypeptides)
IBA
11/2012 - 06/2007
2
Tumor Biomarkers (Tumor Markers)
IBA
07/2009 - 12/2005
2
Drug Combinations
IBA
09/2006 - 06/2003
2
HLA-DR Antigens (HLA-DR)
IBA
06/2004 - 08/2002
1
Peptide Receptors (Peptide Receptor)
IBA
03/2022
1
Radioisotopes (Radionuclides)
IBA
03/2022
1
Deoxyglucose (2 Deoxy D glucose)
IBA
02/2022
1
Hemoglobins (Hemoglobin)
IBA
01/2022
1
encorafenib
IBA
10/2021
1
binimetinib
IBA
10/2021
1
Creatine Kinase (Creatine Phosphokinase)
IBA
10/2021
1
Transferases
IBA
10/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2021
1
Dipyrone (Metamizole)
IBA
01/2021
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
01/2021
1
C-Peptide
IBA
01/2021
1
Blood Glucose (Blood Sugar)
IBA
01/2021
1
dimemorfan (AT 17)
IBA
01/2021
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2021
1
Antiviral Agents (Antivirals)
IBA
01/2021
1
cyclopropapyrroloindole
IBA
01/2021
1
cobimetinib
IBA
01/2021
1
Lipase (Acid Lipase)
FDA Link
01/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2021
Therapy/Procedure
67
Therapeutics
04/2022 - 08/2002
15
Immunotherapy
04/2022 - 05/2008
12
Drug Therapy (Chemotherapy)
10/2017 - 01/2003
7
Radiotherapy
03/2022 - 04/2007
3
Aftercare (After-Treatment)
03/2021 - 04/2007
2
Combination Drug Therapy (Combination Chemotherapy)
09/2017 - 04/2007
2
Palliative Care (Palliative Therapy)
06/2008 - 01/2007
1
Withholding Treatment
05/2021